A Republican-led bill aiming to tighten Medicaid eligibility and impose work requirements sparked heated protests and clashes ...

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...

Healthcare providers expressed concerns about the accuracy gaps in AI image analysis for non-white skin tones or low digital ...

Witty was the top executive of the country's largest healthcare company during some of its darkest chapters, including the ...

Their concerns come in response to the bill unveiled Sunday night by House Republicans that would tighten eligibility rules, ...

Homelessness and HIV share common risk factors, according to Julie Dombrowski, M.D., M.P.H., professor of medicine at the ...

The House Energy and Commerce Committee has scheduled a public markup hearing for the Republican bill for tomorrow at 2 p.m.

Industry leaders and policy experts have said President Trump’s executive order on Most Favored Pricing is flawed and ignores the basic economics of the global drug marketplace.

In a press conference, President Donald J. Trump announced that he would sign an executive order that ties drug pricing to ...

Healthcare providers are exploring ways to reduce patient travel through a growing trend of expanding sites of administration ...

A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...